• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case

Mary Wilson

Well-known member
Volume 238, October 2022, 154106

https://doi.org/10.1016/j.prp.2022.154106

ManaTaweevisit[SUP]a[/SUP][SUP]b[/SUP]AriyaChindamporn[SUP]b[/SUP][SUP]c[/SUP]KritsapornSujjavorakul[SUP]d[/SUP][SUP]e[/SUP]RujipatSamransamruajkit[SUP]b[/SUP][SUP]e[/SUP]Paul ScottThorner[SUP]a[/SUP][SUP]f[/SUP]

Highlights

•We report the first autopsy on a MIS-C patient from Asia, the 6th reported worldwide.
•Autopsy showed disseminated aspergillosis and SARS-COV-2 virus in multiple organs.
•This is the first report of aspergillosis in a MIS-C patient.
•Persistence of SARS-COV-2 has been found in all reported autopsies of MIS-C patients.
•MIS-C as a post-infectious hyperimmune reaction may be an oversimplification.

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is an emerging phenomenon associated with SARS-COV-2 infection (COVID-19) occurring in < 1 % of infected children. MIS-C is characterized by a hyperinflammatory state with excessive cytokine release (‘storm’) leading to hemodynamic compromise and multiorgan failure, with a death rate of ∼2 %. Autopsy examination can play a particularly important role in helping to understand the pathogenesis of MIS-C. Yet, only five autopsy studies have been reported to date. We report a fatal case of MIS-C involving a previously healthy, 5-year-old Thai boy admitted with MIS-C, one month after exposure to SARS-COV-2. While in intensive care, he was found to have a hypertrophic cardiomyopathy, and despite immunosuppressive treatment for MIS-C, developed shock and died. Multiorgan inflammation was not found at autopsy, implying that the MIS-C had responded to treatment. However, there was disseminated aspergillosis and cytomegalovirus reactivation, attributed to the immunosuppression. SARS-COV-2 virus was also found in multiple organs. To the best of our knowledge, this is the first reported autopsy of an MIS-C patient from Asia, and the first report of aspergillosis in MIS-C. This case underscores that the risks of immunosuppression are also a concern in MIS-C. Although MIS-C is generally considered to be a post-infectious hyperimmune reaction, persistence of SARS-COV-2 is a feature in all autopsies of MIS-C patients reported to date, suggesting a possible role in the pathogenesis, at least in fatal cases.

https://www.sciencedirect.com/science/article/pii/S0344033822003508
 
Back
Top Bottom